Scandinavian CRO (SCRO) and Cardialysis are contract research organizations (CROs) in the field of clinical research, with a common goal of improving patient care and developing new treatments. Last year, SCRO and Cardialysis initiated a long-term collaboration to work together to accelerate innovation in the life sciences.
During the past year, SCRO and Cardialysis collaborated in a clinical study to investigate a novel medical device in patients suffering from cryptogenic stroke. SCRO played a key role in monitoring the study and managing study sites in Scandinavia.
“We have a clear synergism with SCRO, which was successfully demonstrated in this study, and we look forward to exploring additional areas of collaboration,” says Ernest Spitzer, CEO at Cardialysis.
“Ultimately, our shared goal is to provide patients with better clinical outcomes and improved quality of life,” adds Ulrika Hammarström, Founder and CEO at Scandinavian CRO.
Related links:
Cardialysis on LinkedIn
